Moderna, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
MRNA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
325 Binney Street, Cambridge, Massachusetts

Insiders trading volume in the past year

Moderna, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stephane Bancel Chief Executive Officer, Director $1.81 B -$2.34 M -0.13% Jun 14, 2024
Noubar Afeyan Director $927 M -$82.4 M -8.16% Jun 26, 2024
Stephen Hoge President $224 M -$21.3 M -8.72% Jun 17, 2024
Stephen Berenson Director $2.52 M May 3, 2024
Shannon Thyme Klinger Chief Legal Officer $2.36 M -$1.28 M -35.1% Jun 7, 2024
Arpa Garay Chief Commercial Officer $1.52 M -$106 K -6.53% Dec 5, 2023
James M. Mock Chief Financial Officer $1.44 M -$740 K -34% May 31, 2024
Juan Andres Chief Technical Operations and Quality Officer $1.33 M Dec 28, 2022
David W. Meline Chief Financial Officer $645 K Aug 9, 2022
Paul Burton Chief Medical Officer $542 K Nov 4, 2022
Elizabeth G. Nabel Director $350 K May 3, 2024
Sandra Horning Director $111 K May 6, 2024
Lori M. Henderson General Counsel and Secretary $93.6 K May 27, 2021
Tal Zvi Zaks Chief Medical Officer Jun 30, 2021
Robert Langer Director May 6, 2024
Jorge M. Gomez Officer May 9, 2022
Francois Nader Director May 6, 2024
Elizabeth E. Tallett Director May 6, 2024
Paul Sagan Director May 6, 2024

Recent Insider Transactions by Companies or Individuals for Moderna, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership